EntreMed Regains Nasdaq Compliance With Shareholders' Equity Listing Requirement

EntreMed, Inc. ENMD announced today that it has received notice from the Nasdaq Stock Market indicating that, based on the Company's completed financing described in the Company's Form 8-K dated May 4, 2012, the NASDAQ staff has determined that the Company complies with Listing Rule 5550(b). The Company was previously notified that it was not in compliance with Nasdaq Listing Rule 5550(b) and was granted an extension until May 21, 2012 to comply. Listing Rule 5550(b) requires listed companies to have a minimum $2,500,000 stockholders' equity, $35,000,000 market value of listed securities, or $500,000 net income from continuing operations. In accordance with NASDAQ Marketplace Rules, NASDAQ will continue to monitor the Company's ongoing compliance with Rule 5550(b) and will require the Company to evidence compliance upon filing its periodic report for the quarter ending June 30, 2012, or it may be subject to delisting which can be appealed.